Suppr超能文献

相似文献

1
Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile.
Sci Rep. 2018 Mar 19;8(1):4797. doi: 10.1038/s41598-018-23140-9.
2
A new opportunity for nanomedicines: Micellar cytochrome P450 inhibitors to improve drug efficacy in a cancer therapy model.
Nanomedicine. 2017 Jul;13(5):1715-1723. doi: 10.1016/j.nano.2017.03.006. Epub 2017 Mar 23.
3
Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy.
Colloids Surf B Biointerfaces. 2019 Jan 1;173:366-377. doi: 10.1016/j.colsurfb.2018.10.007. Epub 2018 Oct 4.
4
Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.
Pharm Nanotechnol. 2017;5(1):3-23. doi: 10.2174/2211738505666161230110108.
6
Liposomal nanomedicine for breast cancer therapy.
Nanomedicine (Lond). 2011 Aug;6(6):1085-100. doi: 10.2217/nnm.11.72.
7
Theranostics with Hybrid Liposomes in an Orthotopic Graft Model Mice of Breast Cancer.
Anticancer Res. 2018 Oct;38(10):5645-5654. doi: 10.21873/anticanres.12900.
8
Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.
Int J Nanomedicine. 2017 Aug 2;12:5537-5556. doi: 10.2147/IJN.S141145. eCollection 2017.
10
Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes.
Colloids Surf B Biointerfaces. 2018 Dec 1;172:213-223. doi: 10.1016/j.colsurfb.2018.08.047. Epub 2018 Aug 23.

引用本文的文献

3
Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies.
Science. 2024 Jan 19;383(6680):eadf2341. doi: 10.1126/science.adf2341.
4
Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials.
Exploration (Beijing). 2023 Jan 5;3(1):20220045. doi: 10.1002/EXP.20220045. eCollection 2023 Feb.
5
Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management.
Biology (Basel). 2023 Apr 27;12(5):665. doi: 10.3390/biology12050665.
6
Reducing off-target drug accumulation by exploiting a type-III interferon response.
J Control Release. 2023 Jun;358:729-738. doi: 10.1016/j.jconrel.2023.05.029. Epub 2023 May 27.
7
Novel Developments to Enable Treatment of CNS Diseases with Targeted Drug Delivery.
Pharmaceutics. 2023 Mar 29;15(4):1100. doi: 10.3390/pharmaceutics15041100.
8
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs.
Nat Rev Mater. 2023;8(4):282-300. doi: 10.1038/s41578-022-00529-7. Epub 2023 Jan 19.
9
Radiation nanosensitizers in cancer therapy-From preclinical discoveries to the outcomes of early clinical trials.
Bioeng Transl Med. 2021 Sep 23;7(1):e10256. doi: 10.1002/btm2.10256. eCollection 2022 Jan.
10
Delivering the power of nanomedicine to patients today.
J Control Release. 2020 Oct 10;326:164-171. doi: 10.1016/j.jconrel.2020.07.007. Epub 2020 Jul 15.

本文引用的文献

1
Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.
Int J Nanomedicine. 2017 Aug 2;12:5537-5556. doi: 10.2147/IJN.S141145. eCollection 2017.
2
In vivo tumor targeting and biodistribution evaluation of paramagnetic solid lipid nanoparticles for magnetic resonance imaging.
Nanomedicine. 2017 Feb;13(2):693-700. doi: 10.1016/j.nano.2016.09.012. Epub 2016 Oct 5.
3
Drug Development of Therapeutic Monoclonal Antibodies.
BioDrugs. 2016 Aug;30(4):275-93. doi: 10.1007/s40259-016-0181-6.
4
Antibody-drug conjugates for cancer therapy.
Lancet Oncol. 2016 Jun;17(6):e254-e262. doi: 10.1016/S1470-2045(16)30030-4.
5
Cellular distribution of injected PLGA-nanoparticles in the liver.
Nanomedicine. 2016 Jul;12(5):1365-74. doi: 10.1016/j.nano.2016.01.013. Epub 2016 Mar 4.
6
Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics.
Clin Pharmacokinet. 2016 Jul;55(7):789-805. doi: 10.1007/s40262-015-0361-4.
7
Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination.
J Control Release. 2016 Oct 28;240:332-348. doi: 10.1016/j.jconrel.2016.01.020. Epub 2016 Jan 13.
8
Safety of Nanoparticles in Medicine.
Curr Drug Targets. 2015;16(14):1671-81. doi: 10.2174/1389450115666140804124808.
9
Chemotherapy-induced peripheral neuropathy: Current status and progress.
Gynecol Oncol. 2016 Jan;140(1):176-83. doi: 10.1016/j.ygyno.2015.11.011. Epub 2015 Nov 7.
10
Principles of nanoparticle design for overcoming biological barriers to drug delivery.
Nat Biotechnol. 2015 Sep;33(9):941-51. doi: 10.1038/nbt.3330.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验